Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study

NCT03394521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 326

Last updated 2026-05-14

No results posted yet for this study

Summary

The purpose of this study is to measure how many patients develop worsening glaucoma in the early years (2-4 years) of routine monitoring in hospital eye services. We will study a group of patients who were initially diagnosed as having glaucoma, or having high pressure in the eye (ocular hypertension) or having been diagnosed as a glaucoma suspect.

Conditions

Interventions

OTHER

Routine clinical practice

This is an observational study

Sponsors & Collaborators

  • Queen's University, Belfast

    collaborator OTHER
  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Katie Banister · University of Aberdeen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-08-31
Completion
2016-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394521 on ClinicalTrials.gov